Contraindicated (one)pentobarbital will decrease the level or impact of cariprazine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is accountable for the development and elimination of cariprazine's active metabolites.
pentobarbital will lower the extent or impact of itraconazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Not known.
pentobarbital will reduce the extent or effect of quinine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unfamiliar.
pentobarbital will lessen the extent or effect of vardenafil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
If this drug is utilized all through pregnancy, or If your affected person will become Expecting although using this drug, the client needs to be apprised of your potential hazard for the fetus
Next oral or parenteral administration, barbiturates readily cross the placental barrier and so are dispersed throughout fetal tissues with best concentrations found in the placenta, fetal liver, and brain; fetal blood levels tactic maternal blood amounts pursuing parenteral administration
pentobarbital will reduce the extent or outcome of clozapine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
Contraindicated (1)pentobarbital will lessen the extent or impact of lumacaftor/ivacaftor by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease the extent or impact of docetaxel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unfamiliar.
pentobarbital will reduce the level or effect of aprepitant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
fentanyl transmucosal and pentobarbital both of those increase sedation. Prevent or Use Alternate Drug. Limit use to individuals for whom substitute remedy possibilities are insufficient
Keep track of Intently (1)pentobarbital will minimize the level or effect of glecaprevir/pibrentasvir by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the level or result of ketoconazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Mysterious.
pentobarbital will reduce the extent or more info outcome of alosetron by impacting hepatic enzyme CYP2C9/10 metabolism. Minimal/Significance Unfamiliar.